Cambridge Cognition

Cambridge Cognition develops and commercializes validated digital neuroscience technologies for assessing cognitive function. Their products—including the widely recognized CANTAB® battery—are used globally in pharmaceutical clinical trials, academic research, and healthcare to measure brain health outcomes. The company’s solutions are trusted by top pharmaceutical companies and academic institutions for sensitive detection of cognitive changes across a wide range of CNS-related indications. Their platforms support both in-clinic and remote/decentralized assessments using mobile devices or wearables. The company has over three decades of scientific validation behind its offerings.